FONAR CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that FONAR CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $104.35M | Sep 22, 2025 |
| FY2025 | Jun 30, 2024 | $102.88M | Sep 22, 2025 |
| FY2024 | Jun 30, 2023 | $98.65M | Sep 27, 2024 |
| FY2023 | Jun 30, 2022 | $97.59M | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $89.93M | Sep 28, 2022 |
| FY2021 | Jun 30, 2020 | $85.69M | Oct 13, 2021 |
| FY2020 | Jun 30, 2019 | $87.19M | Oct 1, 2020 |
| FY2019 | Jun 30, 2018 | $81.52M | Sep 30, 2019 |
| FY2019 | Jun 30, 2017 | $78.04M | Sep 30, 2019 |
| FY2018 | Jun 30, 2016 | $2.14M | Sep 21, 2018 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Jun 30, 2018 | $81.52M | Sep 21, 2018 |
| FY2018 | Jun 30, 2017 | $78.04M | Sep 21, 2018 |
| FY2018 | Jun 30, 2016 | $73.37M | Sep 21, 2018 |
| FY2015 | Jun 30, 2015 | $16.88M | Sep 29, 2015 |
| FY2015 | Mar 31, 2015 | $17.10M | Sep 29, 2015 |
| FY2015 | Dec 31, 2014 | $17.09M | Sep 29, 2015 |
| FY2015 | Sep 30, 2014 | $17.99M | Sep 29, 2015 |
| FY2015 | Jun 30, 2014 | $17.03M | Sep 29, 2015 |
| FY2015 | Mar 31, 2014 | $17.04M | Sep 29, 2015 |
| FY2015 | Dec 31, 2013 | $17.61M | Sep 29, 2015 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $8.33M | Sep 22, 2025 |
| FY2025 | Jun 30, 2024 | $10.57M | Sep 22, 2025 |
| FY2024 | Jun 30, 2023 | $9.38M | Sep 27, 2024 |
| FY2023 | Jun 30, 2022 | $12.44M | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $10.21M | Sep 28, 2022 |
| FY2021 | Jun 30, 2020 | $8.24M | Oct 13, 2021 |
| FY2020 | Jun 30, 2019 | $15.32M | Oct 1, 2020 |
| FY2019 | Jun 30, 2018 | $21.23M | Sep 30, 2019 |
| FY2019 | Jun 30, 2017 | $19.62M | Sep 30, 2019 |
| FY2018 | Jun 30, 2016 | $15.72M | Sep 21, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Jun 30, 2024 | $4.52M | Sep 27, 2024 |
| FY2023 | Jun 30, 2023 | $11.13M | Sep 28, 2023 |
| FY2022 | Jun 30, 2022 | $5.31M | Sep 28, 2022 |
| FY2021 | Jun 30, 2021 | ($7.09M) | Oct 13, 2021 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $1.58M | Sep 22, 2025 |
| FY2025 | Jun 30, 2024 | $1.74M | Sep 22, 2025 |
| FY2024 | Jun 30, 2023 | $1.57M | Sep 27, 2024 |
| FY2023 | Jun 30, 2022 | $1.49M | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $1.64M | Sep 28, 2022 |
| FY2021 | Jun 30, 2020 | $2.03M | Oct 13, 2021 |
| FY2020 | Jun 30, 2019 | $1.81M | Oct 1, 2020 |
| FY2019 | Jun 30, 2018 | $1.76M | Sep 30, 2019 |
| FY2019 | Jun 30, 2017 | $1.48M | Sep 30, 2019 |
| FY2018 | Jun 30, 2016 | $1.63M | Sep 21, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $29.73M | Sep 22, 2025 |
| FY2025 | Jun 30, 2024 | $26.87M | Sep 22, 2025 |
| FY2024 | Jun 30, 2023 | $29.39M | Sep 27, 2024 |
| FY2023 | Jun 30, 2022 | $23.51M | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $24.74M | Sep 28, 2022 |
| FY2021 | Jun 30, 2020 | $26.72M | Oct 13, 2021 |
| FY2020 | Jun 30, 2019 | $19.26M | Oct 1, 2020 |
| FY2019 | Jun 30, 2018 | $18.13M | Sep 30, 2019 |
| FY2019 | Jun 30, 2017 | $19.41M | Sep 30, 2019 |
| FY2018 | Jun 30, 2016 | $18.51M | Sep 21, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $11.26M | Sep 22, 2025 |
| FY2025 | Jun 30, 2024 | $14.09M | Sep 22, 2025 |
| FY2024 | Jun 30, 2023 | $14.47M | Sep 27, 2024 |
| FY2023 | Jun 30, 2022 | $15.30M | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $19.09M | Sep 28, 2022 |
| FY2021 | Jun 30, 2020 | $20.40M | Oct 13, 2021 |
| FY2020 | Jun 30, 2019 | $19.45M | Oct 1, 2020 |
| FY2019 | Jun 30, 2018 | $18.74M | Sep 30, 2019 |
| FY2019 | Jun 30, 2017 | $16.81M | Sep 30, 2019 |
| FY2018 | Jun 30, 2016 | $16.62M | Sep 21, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $3.79M | Sep 22, 2025 |
| FY2025 | Jun 30, 2024 | $790.0K | Sep 22, 2025 |
| FY2024 | Jun 30, 2023 | $4.22M | Sep 27, 2024 |
| FY2023 | Jun 30, 2022 | $4.55M | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $3.53M | Sep 28, 2022 |
| FY2021 | Jun 30, 2020 | $7.52M | Oct 13, 2021 |
| FY2020 | Jun 30, 2019 | $3.36M | Oct 1, 2020 |
| FY2019 | Jun 30, 2018 | ($2.78M) | Sep 30, 2019 |
| FY2019 | Jun 30, 2017 | ($2.85M) | Sep 30, 2019 |
| FY2018 | Jun 30, 2016 | ($712.2K) | Sep 21, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $216.91M | Sep 22, 2025 |
| FY2025 | Jun 30, 2024 | $214.25M | Sep 22, 2025 |
| FY2024 | Jun 30, 2023 | $200.58M | Sep 27, 2024 |
| FY2023 | Jun 30, 2022 | $199.34M | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $189.51M | Sep 28, 2022 |
| FY2021 | Jun 30, 2020 | $180.26M | Oct 13, 2021 |
| FY2020 | Jun 30, 2019 | $133.56M | Oct 1, 2020 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $56.80M | Sep 22, 2025 |
| FY2025 | Jun 30, 2024 | $57.46M | Sep 22, 2025 |
| FY2024 | Jun 30, 2023 | $49.75M | Sep 27, 2024 |
| FY2023 | Jun 30, 2022 | $53.11M | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $54.14M | Sep 28, 2022 |
| FY2021 | Jun 30, 2020 | $54.02M | Oct 13, 2021 |
| FY2020 | Jun 30, 2019 | $15.45M | Oct 1, 2020 |
| FY2019 | Jun 30, 2018 | $16.08M | Sep 30, 2019 |
| FY2018 | Jun 30, 2017 | $15.85M | Sep 21, 2018 |
| FY2017 | Jun 30, 2016 | $24.11M | Sep 27, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $172.61M | Sep 22, 2025 |
| FY2025 | Jun 30, 2024 | $165.97M | Sep 22, 2025 |
| FY2024 | Jun 30, 2023 | $157.91M | Sep 27, 2024 |
| FY2023 | Jun 30, 2022 | $150.29M | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $138.42M | Sep 28, 2022 |
| FY2021 | Jun 30, 2020 | $126.19M | Oct 13, 2021 |
| FY2020 | Jun 30, 2019 | $115.96M | Oct 1, 2020 |
| FY2019 | Jun 30, 2018 | $98.68M | Sep 30, 2019 |
| FY2018 | Jun 30, 2017 | $82.91M | Sep 21, 2018 |
| FY2018 | Jun 30, 2016 | $60.78M | Sep 21, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $4.27M | Sep 22, 2025 |
| FY2025 | Jun 30, 2024 | $4.27M | Sep 22, 2025 |
| FY2024 | Jun 30, 2023 | $4.27M | Sep 27, 2024 |
| FY2023 | Jun 30, 2022 | $4.27M | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $4.27M | Sep 28, 2022 |
| FY2022 | Mar 29, 2021 | $283.9K | Sep 28, 2022 |
| FY2021 | Jun 30, 2020 | $3.99M | Oct 13, 2021 |
| FY2020 | Jun 30, 2019 | $3.99M | Oct 1, 2020 |
| FY2019 | Jun 30, 2018 | $3.99M | Sep 30, 2019 |
| FY2018 | Jun 30, 2017 | $3.93M | Sep 21, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($5.29M) | Sep 22, 2025 |
| FY2025 | Jun 30, 2024 | ($13.62M) | Sep 22, 2025 |
| FY2024 | Jun 30, 2023 | ($24.19M) | Sep 27, 2024 |
| FY2023 | Jun 30, 2022 | ($33.57M) | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | ($46.01M) | Sep 28, 2022 |
| FY2021 | Jun 30, 2020 | ($56.22M) | Oct 13, 2021 |
| FY2020 | Jun 30, 2019 | ($64.46M) | Oct 1, 2020 |
| FY2019 | Jun 30, 2018 | ($79.77M) | Sep 30, 2019 |
| FY2018 | Jun 30, 2017 | ($101.00M) | Sep 21, 2018 |
| FY2017 | Jun 30, 2016 | ($120.62M) | Sep 27, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $56.33M | Sep 22, 2025 |
| FY2025 | Jun 30, 2024 | $56.34M | Sep 22, 2025 |
| FY2024 | Jun 30, 2023 | $51.28M | Sep 27, 2024 |
| FY2021 | Jun 30, 2021 | $44.46M | Oct 13, 2021 |
| FY2021 | Jun 30, 2020 | $36.80M | Oct 13, 2021 |
| FY2021 | Jun 30, 2019 | $13.88M | Oct 13, 2021 |
| FY2019 | Mar 31, 2019 | $9.8K | Sep 30, 2019 |
| FY2020 | Jun 30, 2018 | $19.63M | Oct 1, 2020 |
| FY2019 | Jun 30, 2017 | $10.14M | Sep 30, 2019 |
| FY2019 | Jun 30, 2016 | $8.53M | Sep 30, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Jun 30, 2024 | $113.9K | Sep 27, 2024 |
| FY2024 | Jun 30, 2023 | $158.8K | Sep 27, 2024 |
| FY2013 | Jun 30, 2013 | $634.4K | Oct 15, 2013 |
| FY2013 | Jun 30, 2012 | $416.8K | Oct 15, 2013 |
| FY2012 | Jun 30, 2011 | $480.9K | Oct 26, 2012 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Jun 30, 2022 | 1 | Sep 28, 2022 |
| FY2022 | Jun 30, 2021 | 1 | Sep 28, 2022 |
| FY2020 | Jun 30, 2020 | 1 | Oct 1, 2020 |
| FY2020 | Jun 30, 2019 | 2 | Oct 1, 2020 |
| FY2016 | Jun 30, 2016 | 2 | Sep 28, 2016 |
| FY2015 | Jun 30, 2015 | 0 | Sep 29, 2015 |
| FY2015 | Mar 31, 2015 | 0 | Sep 29, 2015 |
| FY2015 | Dec 31, 2014 | 0 | Sep 29, 2015 |
| FY2015 | Sep 30, 2014 | 0 | Sep 29, 2015 |
| FY2015 | Jun 30, 2014 | 0 | Sep 29, 2015 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2015 | Jun 30, 2015 | 0 | Sep 29, 2015 |
| FY2015 | Mar 31, 2015 | 0 | Sep 29, 2015 |
| FY2015 | Dec 31, 2014 | 0 | Sep 29, 2015 |
| FY2015 | Sep 30, 2014 | 0 | Sep 29, 2015 |
| FY2015 | Jun 30, 2014 | 0 | Sep 29, 2015 |
| FY2015 | Mar 31, 2014 | 0 | Sep 29, 2015 |
| FY2015 | Dec 31, 2013 | 0 | Sep 29, 2015 |
| FY2015 | Sep 30, 2013 | 0 | Sep 29, 2015 |